Drug firm announces advance in quest for HIV cure

December 22, 2015

HIV (yellow) infecting a human immune cell. Credit: Seth Pincus, Elizabeth Fischer and Austin Athman, National Institute of Allergy and Infectious Diseases, National Institutes of Health
A Norwegian drug firm on Tuesday announced an advance in its quest for an HIV cure with a drug combination which seeks to force the virus out of its hiding place and kill it.

A trial with 17 HIV-positive patients yielded a "statistically signficant decrease" in the , biotech firm Bionor announced.

"This is a major achievement on the path to a functional for HIV," Bionor spokesman Jorgen Fischer Ravn told AFP.

There is no cure for the disease AIDS, caused by HIV. but anti-retroviral treatments help people live longer, healthier lives by delaying and subduing symptoms.

In some who undergo treatment, however, the virus takes cover in cells and hides away, only to reemerge once therapy is stopped.

This latency has been one of the biggest hurdles in developing a cure.

"Waking up" the virus and then destroying it—the so-called "kick-and-kill" approach—is a promising strategy for ridding patients of HIV.

Bionor's approach involves an anti-cancer called romidepsin to wake up the dormant HIV, and a vaccine called Vacc-4x to prime the body's own immune T-cells to recognise and destroy the virus.

"After an activation of the virus, which would normally lead to detectable virus in the blood, Vacc-4x ensured killing of the virus-producing cells to maintain non-detectable or very low levels of virus in the blood in 15 out of 17 ," said Fischer Ravn.

No-one has yet been cured of AIDS.

Thirty-nine million people have died of AIDS, according to UN estimates, and about 35 million are living with the immune system-destroying virus today, overwhelmingly in poor countries.

Explore further: Alcoholism drug may help design HIV cure, study says

Related Stories

Alcoholism drug may help design HIV cure, study says

November 17, 2015
A treatment for alcoholism can reactivate dormant HIV, potentially allowing other drugs to spot and kill the virus hiding out in human immune cells, researchers said Tuesday.

Targeting HIV 'reservoir' could be first step to understanding how to cure the disease

December 1, 2015
A new clinical trial will test whether it is possible to destroy hidden reservoirs of HIV virus that are a key obstacle to curing the disease.

AIDS cure: Study sees advance for 'kick and kill' strategy

July 22, 2014
The elusive quest for an HIV cure received a boost at the world AIDS conference Tuesday as scientists said they had forced the virus out of a hiding place where it had lurked after being suppressed by drugs.

World AIDS Day brings optimism for cure on horizon within five years

December 2, 2015
After nearly three decades of battling the HIV virus, Frank Brooks is daring to believe what once seemed unthinkable: A life free of AIDS.

Cancer drug promises to break down barrier to HIV cure

September 18, 2015
Researchers have found a promising way of kicking the AIDS virus out of its hiding place in infected cells, potentially removing the main obstacle to curing HIV.

Bill Gates hopeful of AIDS vaccine in 10 years

June 26, 2015
Billionaire and philanthropist Bill Gates, who spends millions of dollars on AIDS drug development, said Friday he hoped for a vaccine against the disease within the next decade as a cure remains far off.

Recommended for you

HIV vaccine protects non-human primates from infection

December 14, 2018
For more than 20 years, scientists at Scripps Research have chipped away at the challenges of designing an HIV vaccine. Now new research, published in Immunity, shows that their experimental vaccine strategy works in non-human ...

Roadmap reveals shortcut to recreate key HIV antibody for vaccines

December 11, 2018
HIV evades the body's immune defenses through a multitude of mutations, and antibodies produced by the host's immune system to fight HIV also follow convoluted evolutionary pathways that have been challenging to track.

Eliminating the latent reservoir of HIV

December 7, 2018
A new study suggests that a genetic switch that causes latent HIV inside cells to begin to replicate can be manipulated to completely eradicate the virus from the human body. Cells harboring latent HIV are "invisible" to ...

New research highlights why HIV-infected patients suffer higher rates of cancer

December 5, 2018
AIDS patients suffer higher rates of cancer because they have fewer T-cells in their bodies to fight disease. But new research examines why HIV-infected patients have higher rates of cancer—among the leading causes of death ...

Focus on resistance to HIV offers insight into how to fight the virus

November 30, 2018
Of the 40 million people around the world infected with HIV, less than one per cent have immune systems strong enough to suppress the virus for extended periods of time. These special immune systems are known as "elite controllers." ...

Patients with rare natural ability to suppress HIV shed light on potential functional cure

November 27, 2018
Researchers at Johns Hopkins have identified two patients with HIV whose immune cells behave differently than others with the virus and actually appear to help control viral load even years after infection. Moreover, both ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.